MTOR and neoplasm: Taken together, these results strongly demonstrate a synergistic effect at this dose and indicate that the VEGF inhibitor, bevacizumab (Avastin®) and the mTOR inhibitor, temsirolimus (Torisel®), are exponentially effective at blocking tumor vascularization in combination.